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Abstract: The spine-bellied sea snake (Hydrophis curtus) is known to cause human deaths, yet its
venom composition has not yet been proteomically characterised. An in-depth proteomic analysis was
performed on H. curtus venom from two different seasons, January and June, corresponding to adults
and subadults, respectively. Venoms from adult and subadult H. curtus individuals were compared
using reversed-phase high-performance liquid chromatography (RP-HPLC), matrix-assisted laser
desorption ionisation-time of flight (MALDI-TOF) mass spectrometry and liquid chromatography
electrospray ionisation mass spectrometry (LC-ESI-MS) to detect intraspecific variation, and the
molecular weight data obtained with ESI-MS were used to assess toxin diversity. RP-HPLC and
LC-ESI-MS/MS were used to characterise the venom proteome and estimate the relative abundances
of protein families present. The most abundant protein family in January and June venoms is
phospholipase A2 (PLA2: January 66.7%; June 54.5%), followed by three-finger toxins (3FTx: January
30.4%; June 40.4%) and a minor component of cysteine-rich secretory proteins (CRISP: January
2.5%; June 5%). Trace amounts of snake venom metalloproteinases (SVMP), C-type lectins and
housekeeping and regulatory proteins were also found. Although the complexity of the venom
is low by number of families present, each family contained a more diverse set of isoforms than
previously reported, a finding that may have implications for the development of next-generation sea
snake antivenoms. Intraspecific variability was shown to be minor with one obvious exception of a
14,157-Da protein that was present in some January (adult) venoms, but not at all in June (subadult)
venoms. There is also a greater abundance of short-chain neurotoxins in June (subadult) venom
compared with January (adult) venom. These differences potentially indicate the presence of seasonal,
ontogenetic or sexual variation in H. curtus venom.
Keywords: Hydrophis curtus; spine-bellied sea snake; sea snake venom; venom proteome; venomics;
intraspecific variation
1. Introduction
The viviparous sea snakes (Elapidae: Hydrophiinae: Hydrophinii) consist of 62 species that are
phylogenetically placed within the terrestrial elapids [1]. Phylogenetic relationships among sea snakes
have been clarified in recent years, with Hydrophis and Aipysurus emerging as the two major clades [1].
Sea snakes are widespread in the shallow tropical and subtropical marine waters of northern Australia,
the western Pacific and Indian Oceans and the Persian Gulf [2,3], feeding predominantly on sedentary,
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bottom-dwelling fish [4]. Two or three are generalist feeders, whereas most are specialists, favouring
prey such as eels, gobies and catfish [4].
Sea snake venoms are relatively simple mixtures, containing a limited number of toxin families
and isoforms [5,6], potentially as a result of their limited fish diet, which is believed to require a minimal
suite of toxins [5]. Characteristically, the venom is dominated by toxins from two protein families, the
neurotoxic three-finger toxins (3FTx) and myotoxic phospholipase A2 (PLA2) [6–9]. Sea snake venom
can be dangerous to humans, in severe cases causing myolysis and/or neuromuscular paralysis that can
be lethal without prompt treatment [10–13]. Most at risk are Asian fishermen using traditional methods,
who encounter the animals when handling nets or sorting fish [12]. The spine-bellied sea snake
(Hydrophis curtus; synonymous with Lapemis curtus, Lapemis hardwickii and Hydrophis hardwickii) [14],
the most generalist feeder of all the sea snakes [4], is one of the species known to be responsible for
human fatalities [15,16]. It is all the more hazardous because it is likely to be encountered by people,
being one of the most widely-distributed sea snakes, found from northern Australia to the Persian
Gulf via Southeast Asia [14], and is common throughout much of its range [12,15,17]. Further, it is
prone to biting defensively if captured, such as if caught in a fishing net [18].
The degree of intraspecific venom variation in sea snakes is unclear as little work has been
done and the available evidence is contradictory. In H. curtus venom, liquid chromatography
electrospray ionisation mass spectrometry (LC-ESI-MS) shows some differences in the molecular
weights of venom proteins between widely-separated populations [5], suggesting compositional
variation may exist. Conversely, studies on other species comparing reversed-phase high-performance
liquid chromatography (RP-HPLC) chromatograms show limited variation, even between allopatric
populations [6,8]. Fourteen toxins in total have been isolated and sequenced from H. curtus venom.
There are four PLA2 toxins (Q8UW30, Q8UW08, A3FM57 and Q8UW31) [19,20], three 3FTx short-chain
α-neurotoxins (P68416, Q8UW26 and Q8UW27) [21,22] and three 3FTx long-chain α-neurotoxins
(Q8UW28, A3FM53 and Q8UW29) [19]. Two cysteine-rich secretory proteins (CRISP) (Q8UW25 and
Q8UW11) [23], a snake venom serine protease (SVSP) (Q5MCS0) [24] and a C-type lectin (A3FM55) have
also been found [19]. In accordance with the presence of 3FTx, H. curtus venom shows post-synaptic
neurotoxicity in chick biventer cervicis nerve-muscle preparations [25]. The venom demonstrates
myotoxicity in mice [26], consistent with the presence of PLA2 toxins, and shows only low levels of
other enzymatic activity [27]. An estimate of the relative proportions of toxin families in H. curtus
venom was attempted using cDNA cloned from venom gland mRNA, suggesting the venom contained
43.4% 3FTx, 9.8% PLA2 and 2.3% CRISP [28].
The composition of H. curtus venom has not yet been comprehensively determined with proteomic
analysis. In fact, the venom proteomes of only four sea snakes have been published so far, despite
the group’s medical significance [6–9]. To increase understanding of sea snake venoms, and H. curtus
venom specifically, this study presents a proteomic analysis of pooled H. curtus venom from two
different seasons, January and June, corresponding to adults and subadults, respectively. RP-HPLC
and LC-ESI-MS/MS were employed to characterise the venom proteome and estimate the relative
abundances of protein families present using a modified version of the “snake venomics” workflow
proposed by Calvete [29]. Additionally, intraspecific venom variation was assessed with RP-HPLC,
matrix-assisted laser desorption ionisation-time of flight (MALDI-TOF) mass spectrometry and
LC-ESI-MS, and toxin diversity was assessed using the data obtained with LC-ESI-MS.
2. Results
2.1. Assessment of Variation in H. curtus Venom
To determine the presence of any intraspecific variation present in H. curtus venom, the venom
composition was analysed and compared by RP-HPLC and LC-MS. An initial comparison of the same
venom sample by RP-HPLC using a C4 and a C12 column showed improved peak resolution with the
C4 column. A comparison of RP-HPLC chromatograms from January and June pooled samples shows
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most peaks are common (Figure 1). January venom has three extra peaks, 4b, 5b and the peak marked
with an asterisk (*). June venom has one peak not present in January venom (6c). ESI-MS molecular
weight data were generally congruent between June Peak 4 and January Peaks 4a and 4b; June Peak 5
and January Peaks 5a and 5b; and June Peaks 6a–6c and January Peaks 6a–6b (Table 1). In most of
the exceptions, the molecular weights were detected in neighbouring peaks of the other venom or
were present in small quantities, with the exception of a molecule 13,336 Da in size that was abundant
in Peak 4a of the January pool. The peak marked with an asterisk (*), which corresponds to 2.5% of
the total peak area of the RP-HPLC chromatogram, predominantly consists of a molecule 14,157 Da
in size. In individual January adults, this peak varies in abundance and presence. In a comparison
of three representative individuals (Figure 2A–C), the peak is present and comparatively abundant
in Sample 11 at 7.2% of total peak area (Figure 2A), reduced in Sample 9 to 0.7% of total peak area
(Figure 2B) and virtually non-existent in Sample 5 (Figure 2C). This molecule and the peak are absent
in all June venoms (Figure 3A–C), including the single adult sample available.
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Figure 1. Reversed-phase high-performance liquid chromatography (RP-HPLC) chromatogram 
comparison of pooled January and June Hydrophis curtus venoms. Two groups of samples were 
collected from wild-caught snakes in January and June of 2016 and pooled separately. Pooled samples 
were separated by RP-HPLC (Phenomenex Jupiter C4, 4.6 mm × 250 mm, 5 µm, 300 Å) (Phenomenex, 
Torrance, CA, USA) and monitored at 214-nm absorbance to compare protein and peptide 
components. January venom has three extra peaks, 4b, 5b and the peak marked with an asterisk (*). 
June venom has one peak not present in January venom (6c). The dashed line indicates the solvent 
gradient from 0–60% Solvent B. 
Analysis of January individuals by MALDI-TOF mass spectrometry showed that molecular 
weight data were consistent between individuals, with very few exceptions. A comparison of 
MALDI-TOF and ESI-MS showed that the chromatography resolution and molecular weight data 
were consistent between the two (see Figure S1 in Supplementary Materials S9), except that more 
masses were detected with ESI-MS. January and June pooled samples, and all individual June 
samples were therefore analysed by ESI-MS. Figure 4 shows the number, distribution and variation 
of molecules present in the pooled H. curtus samples and three representative June individuals. It 
depicts three discrete clusters of components with molecular weights ranging from 6–8 kDa,  
13–16 kDa and 24–25 kDa, which are consistent with the 3FTx, PLA2 and CRISP protein families, 
respectively [29]. One or two molecular weights are also found in the 20–21 kDa and 43–44 kDa 
ranges. The January and June pools contained 49 and 44 unique molecules respectively. Of those,  
37 were common to both samples, leaving 12 unique molecules in the January pool and seven in the 
June pool. There was more variation between individuals, with the number of molecules found in 
each sample ranging from 26–48. Individual venoms, while showing a high degree of consistency 
Figure 1. Reversed-phase high-performance liquid chromatography (RP-HPLC) chromatogram
comparison of pooled January and June Hydrophis curtus venoms. Two groups of samples were
collected from wild-caught snakes in January and June of 2016 and pooled separately. Pooled samples
were separated by RP-HPLC (Phenomenex Jupiter C4, 4.6 mm × 250 mm, 5 µm, 300 Å) (Phenomenex,
Torrance, CA, USA) and monitored at 214-nm absorbance to compare protein and peptide components.
January venom has three extra peaks, 4b, 5b and the peak marked with an asterisk (*). June venom has
one peak not present in January venom (6c). The dashed line indicates the solvent gradient from 0–60%
Solvent B.
Analysis of January individuals by MALDI-TOF mass spectrometry showed that molecular weight
data were consistent between individuals, with very few exceptions. A comparison of MALDI-TOF
and ESI-MS showed that the chromatography resolution and molecular weight data were consistent
between the two (see Figure S1 in Supplementary Materials S9), except that more masses were detected
with ESI-MS. January and June pooled samples, and all individual June samples were therefore
analysed by ESI-MS. Figure 4 shows the number, distribution and variation of molecules present
in the pooled H. curtus samples and three representative June individuals. It depicts three discrete
clusters of components with molecular weights ranging from 6–8 kDa, 13–16 kDa and 24–25 kDa,
which are consistent with the 3FTx, PLA2 and CRISP protein families, respectively [29]. One or two
molecular weights are also found in the 20–21 kDa and 43–44 kDa ranges. The January and June pools
contained 49 and 44 unique molecules respectively. Of those, 37 were common to both samples, leaving
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12 unique molecules in the January pool and seven in the June pool. There was more variation between
individuals, with the number of molecules found in each sample ranging from 26–48. Individual
venoms, while showing a high degree of consistency between the major components of each peak, did
not contain all molecules, and in some cases, molecules were unique to a single sample. Variation in
the number of molecules between the representative individual venoms is particularly obvious in Bins
13–14 and 15–16 (Figure 4). In the June pool, the proportion of molecules in the 6–8 kDa cluster (3FTx)
accounted for 25.0% of the total versus 59.1% for the 13–16 kDa cluster (PLA2). The breakdown of the
remainder was 11.4% for 24–25 kDa (CRISP) and 2.3% for both 20–21 kDa and 43–44 kDa. The almost
identical January pool breakdown of molecular weights was as follows: 6–8 kDa 24.5%; 13–16 kDa
59.2%; 20–21 kDa 2.0%; 24–25 kDa 10.2%; and 43–44 kDa 4.1%.
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Figure 2. Representative individual Hydrophis curtus venom samples from January 2016, highlighting 
the variable 14-kDa peak. RP-HPLC (Phenomenex Jupiter C4, 4.6 mm × 250 mm, 5 µm, 300 Å) 
(Phenomenex, Torrance, CA, USA) chromatograms of (A) Sample 11, (B) Sample 9 and (C) Sample 5 
are shown and were monitored at 214-nm absorbance. The asterisks point to a peak containing a 
molecular weight of 14,157 Da that is highly variable in its relative abundance and presence. The 
dashed lines indicate the solvent gradient from 0–60% Solvent B. 
2.2. Protein Identification with ProteinPilot and MASCOT 
Searches were conducted using ProteinPilot and MASCOT, and the full results are included in 
Supplementary Tables S1–S8, including MS/MS-derived sequences, mass to charge ratios (m/z) and 
charges (z) from ProteinPilot (Tables S1–S4). Table 1 summarises the results from the ProteinPilot 
searches of all peaks in the June pooled venom (Table S2) and the peak unique to January venom 
(Table S1) against the UniProtKB Serpentes database, as well as the molecular weights detected in 
ESI-MS analysis of January and June pooled venoms. 3FTx toxins are dominant in Peaks 1–3, PLA2 in 
Peaks 4–9b and CRISP in Peak 10. ESI-MS-derived molecular weights consistent with those families 
follow the same pattern. The phosphatidylethanolamine-binding protein 4 (U3FZ77) found in Peak 
9b is consistent with the 20,615-Da molecule found in the same peak. A C-type lectin and a number 
of housekeeping and regulatory proteins are found in Peak 11, and SVMP is found in Peaks 4–5. This 
distribution of protein families is consistent with all other searches performed (Supplementary Tables 
S1–S8). 
Figure 2. Representative individual ydrophis curtus veno sa ples fro January 2016, highlighting
the variable 14-k a peak. P- PL (Pheno enex Jupiter 4, 4.6 250 , 5 µ , 300 )
( heno enex, Torrance, CA, USA) chromatograms of (A) Sample 11, (B) Sample 9 and (C) Sample 5 are
shown and were monitored at 214-nm absorbance. The asterisks point to a peak containing a molecular
weight of 14,157 Da that is highly variable in its relative abundance and presence. The dashed lines
indicate th solvent gradient from 0–60% Solvent B.
2.2. Protein Identification with ProteinPilot and ASCOT
Searches were conducted using ProteinPilot and ASCOT, and the full results are included in
Supplementary Tables S1–S8, including S/ S-derived sequences, mass to charge ratios (m/z) and
charges (z) from ProteinPilot (Tables S1–S4). Table 1 summarises the results from the ProteinPilot
searches of all peaks in the June pooled venom (Table S2) and the peak unique to January venom
(Table S1) against the UniProtKB Serpentes database, as well as the molecular weights detected in
ESI- S analysis of January and June pooled venoms. 3FTx toxins are dominant in Peaks 1–3, PLA2 in
Peaks 4–9b and CRISP in Peak 10. ESI- S-derived molecular weights consistent with those families
follow the same pattern. The phosphatidylethanolamine-binding protein 4 (U3FZ77) found in Peak 9b
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is consistent with the 20,615-Da molecule found in the same peak. A C-type lectin and a number
of housekeeping and regulatory proteins are found in Peak 11, and SVMP is found in Peaks 4–5.
This distribution of protein families is consistent with all other searches performed (Supplementary
Tables S1–S8).
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and three representative June individuals. Molecular weights are divided into 1-kDa molecular 
weight bins. 
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Table 1. Assignment of RP-HPLC fractions by ESI-MS/MS of in-solution trypsin-digested peaks for Hydrophis curtus venom. Protein matches shown are from searches
conducted with ProteinPilot and the Paragon algorithm against the UniProtKB Serpentes database for all peaks in the June pooled venom and from the peak marked
with an asterisk (*) in the January pooled venom. Molecular weight (MW) data from ESI-MS analysis of June and January pooled venoms is listed in approximate
order of descending intensity.
Peak Peak Area % June MW (Da) January MW (Da) Peptides (95%) Score Cov % (95%) Protein Family Related protein (exPASy MW) Species (Accession)
1 10.1
6,688.5
6,745.3
6728.2
6,746.8
6,688.4
6,800.8
43 16.0 58.0 3FTx Short neurotoxin 1 (6689.5) Hydrophis hardwickii (P68416)
2 0.05
6,688.1
6,747.1
6,727.9
6,720.2
7,732.8
6,811.8
6,747.7
6,688.4
6,800.8
6,353.0
6,720.8
6,811.4
7,734.8
16 25.6 33.6 CRISP Cysteine-rich venom protein 1 Hydrophis hardwickii (Q8UW25)
8 13.5 52.2 3FTx α-elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
13 12.0 58.0 3FTx Short neurotoxin 1 (6689.5) Hydrophis hardwickii (P68416)
6 10.2 58.1 3FTx Long neurotoxin 2 Hydrophis hardwickii (A3FM53)
16 9.1 28.6 CRISP Cysteine-rich venom proteinpseudechetoxin-like Notechis scutatus scutatus (Q3SB04)
17 2.0 29.4 CRISP Cysteine-rich secretory protein Cryptophis nigrescens (B5G6G3)
3 22.4
7,632.4
7,574.4
7,556.7
7,614.7
7,632.7
7,574.6
7,686.5
7,614.3
7,556.1
48 54.7 79.4 3FTx Alpha-elapitoxin-Lh2a (7633.7) Hydrophis hardwickii (Q8UW28)
13 16.0 57.6 3FTx Long neurotoxin 1 Hydrophis hardwickii (Q8UW29)
4 6.4 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
9 6.0 58.1 3FTx Long neurotoxin 2 Hydrophis hardwickii (A3FM53)
4 4.2 13.5 CRISP Cysteine-rich venom protein 2 Hydrophis hardwickii (Q8UW11)
2 3.1 7.5 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
8 2.2 20.3 3FTx Toxin Lc a Laticauda colubrina (P0C8R7)
4 4.5
13,252.0
13,307.7
13,325.1
7,632.3
7,574.6
15,670.2
7,733.5
13,336.1
13,308.8
7,632.6
13,328.7
7,574.1
13,251.7
13,389.7
7,614.6
7,686.5
15,726.2
15,672.7
113 93.9 77.4 PLA2 Basic phospholipase A2 73 (13,310.0) Hydrophis hardwickii (Q8UW30)
42 31.2 79.4 3FTx α-elapitoxin-Lh2a (7633.7) Hydrophis hardwickii (Q8UW28)
17 18.8 62.0 3FTx Long neurotoxin 1 Hydrophis hardwickii (Q8UW29)
61 12.2 74.7 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
9 11.7 29.4 CRISP Cysteine-rich venom protein 2 Hydrophis hardwickii (Q8UW11)
4 7.9 58.0 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
14 4.2 29.0 PLA2 Acidic phospholipase A2 57 Hydrophis hardwickii (Q8UW31)
9 4.0 59.1 3FTx Long neurotoxin 2 Hydrophis hardwickii (A3FM53)
6 2.0 28.3 PLA2 PLA-2-Den-2
Denisonia devisi (R4G2S8)
4–5 – – –
154 86.9 76.7 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
117 21.4 75.3 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
29 18.7 69.6 3FTx α-elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
15 12.3 62.0 3FTx Long neurotoxin 1 Hydrophis hardwickii (Q8UW29)
4 7.4 58.0 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
29 5.3 43.4 PLA2 Acidic phospholipase A2 57 Hydrophis hardwickii (Q8UW31)
7 3.2 12.6 CRISP Cysteine-rich venom protein 2 Hydrophis hardwickii (Q8UW11)
29 2.2 26.7 PLA2 Acidic phospholipase A2 S5-32M Austrelaps superbus (Q9PUH4)
3 2.1 4.2 SVMP Nigrescease-1 Cryptophis nigrescens (B5KFV8)
8 2.0 17.7 PLA2 Putative phospholipase A2 Austrelaps labialis (B2BRS9)
4 2.0 20.3 3FTx Toxin Lc b Laticauda colubrina (P0C8R8)
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Table 1. Cont.
Peak Peak Area % June MW (Da) January MW (Da) Peptides (95%) Score Cov % (95%) Protein Family Related protein (exPASy MW) Species (Accession)
5 3.3
13,344.9
13,401.7
7,632.5
7,574.4
13,269.8
13,364.8
13,326.8
13,344.7
13,401.4
7,632.4
7,574.1
116 122.7 76.0 PLA2 Basic phospholipase A2 (13,346.0) Hydrophis hardwickii (Q8UW08)
25 26.7 69.6 3FTx α-elapitoxin-Lh2a (7633.7) Hydrophis hardwickii (Q8UW28)
20 26.0 60.5 PLA2 Acidic phospholipase A2 57 Hydrophis hardwickii (Q8UW31)
73 20.3 67.1 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
8 16.0 22.7 CRISP Cysteine-rich venom protein 1 Hydrophis hardwickii (Q8UW25)
9 12.1 15.2 SVMP Zinc metalloproteinase-disintegrin-like MTP9 Drysdalia coronoides (F8RKV9)
4 8.0 57.6 3FTx Long neurotoxin 1 Hydrophis hardwickii (Q8UW29)
3 6.0 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
16 4.0 34.8 PLA2 Basic phospholipase A2 3 Laticauda semifasciata (P00612)
2 2.0 20.3 3FTx Toxin Lc a Laticauda colubrina (P0C8R7)
* 2.5 –
14,157.2
7,632.1
13,401.6
13,345.2
7,574.6
144 136.6 77.6 PLA2 Acidic phospholipase A2 57 Hydrophis hardwickii (Q8UW31)
56 55.9 72.6 PLA2 Basic phospholipase A2 (13,346.0) Hydrophis hardwickii (Q8UW08)
19 18.6 64.1 3FTx α-elapitoxin-Lh2a (7633.7) Hydrophis hardwickii (Q8UW28)
46 15.5 71.9 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
3 6.0 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
13 6.0 20.4 PLA2 PLA2-Bra-11 Brachyurophis roperi (R4G2E0)
2 4.1 7.6 CRISP Cysteine-rich venom protein 2 Hydrophis hardwickii (Q8UW11)
2 2.7 20.3 3FTx Toxin Lc a Laticauda colubrina (P0C8R7)
8 2.1 29.7 PLA2 Pa-18 Pseudechis australis (Q45Z21)
9 2.0 17.1 PLA2 Acidic phospholipase A2 2 Ophiophagus hannah (Q9DF33)
6a, 6b,
6c
47.9
14,215.4
14,314.8
7,632.6
14,269.3
7,574.8
13,113.8
13,402.4
13,170.5
7,685.9
13,325.3
7,615.0
14,215.5
14,314.6
7,632.4
7,574.3
116 115.2 73.7 PLA2 Acidic phospholipase A2 57 (14,217.0) Hydrophis hardwickii (Q8UW31)
26 20.1 56.2 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
8 14.0 64.1 3FTx α-elapitoxin-Lh2a (7633.7) Hydrophis hardwickii (Q8UW28)
22 10.0 65.8 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
4 6.8 58.0 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
2 4.0 7.6 CRISP Cysteine-rich venom protein 2 Hydrophis hardwickii (Q8UW11)
12 2.1 47.7 PLA2 PLA-2 Notechis scutatus (Q45Z32)
5 1.5 19.0 PLA2 Basic phospholipase A2 2 (Fragment)
Bungarus caeruleus (Q6SLM1)
7 2.7
14,215.4
14,269.6
14,295.5
14,315.1
13,946.5
14,215.4
14,295.5
14,269.9
13,514.1
14,315.2
13,457.4
157 130.3 82.2 PLA2 Acidic phospholipase A2 57 (14,217.0) Hydrophis hardwickii (Q8UW31)
17 10.3 56.9 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
6 6.8 34.8 3FTx α elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
19 6.0 55.5 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
3 5.6 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
16 4.0 45.5 PLA2 Putative phospholipase A2 Austrelaps labialis (B2BRS7)
9 4.0 45.2 PLA2 Acidic phospholipase A2 2 Ophiophagus hannah (Q9DF33)
4 3.2 12.2 CRISP Cysteine-rich venom protein 1 Hydrophis hardwickii (Q8UW25)
12 2.0 46.7 PLA2 PLA2 Hs-1 Hoplocephalus stephensii (A6MJG3)
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Table 1. Cont.
Peak Peak Area % June MW (Da) January MW (Da) Peptides (95%) Score Cov % (95%) Protein Family Related protein (exPASy MW) Species (Accession)
8a, 8b 0.23
14,328.8
14,428.3
14,214.9
14,381.2
14,267.9
14,328.2
14,216.0
14,052.6
14,382.3
14,269.9
76 87.6 78.3 PLA2 Acidic phospholipase A2 57 (14,217.0) Hydrophis hardwickii (Q8UW31)
16 16.4 56.9 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
12 12.9 62.0 3FTx α-elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
4 6.6 16.8 CRISP Cysteine-rich venom protein 1 Hydrophis hardwickii (Q8UW25)
3 6.4 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
18 6.0 55.5 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
6 4.0 31.8 PLA2 PLA-2 Notechis scutatus (Q45Z32)
9a 0.7
15,045.6
15,144.9
14,216.4
14,975.0
15,102.3
14,847.0
14,934.0
15,003.3
15,074.1
15,046.2
15,005.0
15,144.2
15,101.5
14,846.2
14,975.0
14,886.8
15,370.2
64 65.6 80.9 PLA2 Acidic phospholipase A2 57 (14,217.0) Hydrophis hardwickii (Q8UW31)
17 12.6 73.3 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
8 7.8 52.2 3FTx α-elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
18 6.0 61.0 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
3 5.6 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
7 3.1 27.3 CRISP Cysteine-rich venom protein 1
Hydrophis hardwickii (Q8UW25)
9b 0.5
15,044.9
15,004.8
14,845.6
14,934.0
14,215.6
20,615.9
15,045.6
15,004.0
14,846.8
14,214.6
14,933.4
15,099.5
14,973.8
15,145.5
15,073.4
14,886.3
20,614.6
103 99.3 88.2 PLA2 Acidic phospholipase A2 57 (14,217.0) Hydrophis hardwickii (Q8UW31)
20 16.5 47.1 CRISP Cysteine-rich venom protein 1 Hydrophis hardwickii (Q8UW25)
16 13.6 59.0 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
6 6.9 24.3 PEBP Phosphatidylethanolamine-binding protein 4 Micrurus fulvius (U3FZ77)
17 5.6 61.0 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
4 5.4 58.0 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
5 5.0 51.1 3FTx α-elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
2 1.7 3.8 Hsp70 78 kDa glucose-regulated protein Ophiophagus hannah (V8NEC1)
16 1.4 37.0 CRISP Cysteine-rich venom protein 2
Hydrophis hardwickii (Q8UW11)
10 7.5
24,321.2
24,420.2
24,223.2
24,521.0
24,058.7
14,215.2
24,320.5
24,419.6
24,520.7
24,222.4
24,058.3
14,215.2
86 77.4 75.2 CRISP Cysteine-rich venom protein 2 (24,522.8) Hydrophis hardwickii (Q8UW11)
12 9.4 68.4 PLA2 Acidic phospholipase A2 57 (14,217.0) Hydrophis hardwickii (Q8UW31)
6 7.6 37.7 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
4 5.7 28.4 Cys Cystatin Hoplocephalus stephensii (E3P6P0)
3 5.4 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
50 5.3 63.0 CRISP Cysteine-rich venom protein 1 (24,334.8) Hydrophis hardwickii (Q8UW25)
23 4.9 36.1 CRISP Cysteine-rich venom protein pseudechetoxin Pseudechis australis (Q8AVA4)
7 4.7 47.3 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
6 2.7 52.2 3FTx α-elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
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Table 1. Cont.
Peak Peak Area % June MW (Da) January MW (Da) Peptides (95%) Score Cov % (95%) Protein Family Related protein (exPASy MW) Species (Accession)
11 0.13 43,732.5
43,730.9
43,414.4
32 51.2 60.1 CRISP Cysteine-rich venom protein 2 Hydrophis hardwickii (Q8UW11)
13 26.1 67.1 PLA2 Acidic phospholipase A2 57 Hydrophis hardwickii (Q8UW31)
30 14.5 52.5 CRISP Cysteine-rich venom protein 1 Hydrophis hardwickii (Q8UW25)
9 12.6 45.2 PLA2 Basic phospholipase A2 Hydrophis hardwickii (Q8UW08)
5 10.7 5.0 Golgin Golgi apparatus protein 1 (Fragment) Ophiophagus hannah (V8NSK8)
5 10.7 5.8 Trans Transferrin Boiga irregularis (A0A0B8RPR5)
5 7.8 51.1 3FTx α-elapitoxin-Lh2a Hydrophis hardwickii (Q8UW28)
3 6.1 43.2 3FTx Short neurotoxin 1 Hydrophis hardwickii (P68416)
10 6.0 52.7 PLA2 Basic phospholipase A2 73 Hydrophis hardwickii (Q8UW30)
5 6.0 10.5 Nucleo Nucleobindin-2 Micrurus fulvius (U3FBZ2)
2 4.2 11.6 CTL C-type lectin 1 Hydrophis hardwickii (A3FM55)
2 4.1 7.6 PC1A Cathepsin B Micrurus fulvius (U3FD65)
12 4.0 30.7 CRISP Cysteine-rich venom protein pseudechetoxin Pseudechis australis (Q8AVA4)
3 2.2 6.0 Trans Transferrin Boaedon fuliginosus (Q1EL74)
The unique January peak is labelled with an asterisk (*). Peak areas are all calculated from the RP-HPLC chromatogram of June pooled venom, except for the unique January peak, which
is from the RP-HPLC chromatogram of January pooled venom. ESI-MS molecular weights (MW in Da) are listed in approximate descending order of intensity. Molecular weights in
bold blue are similar in size to known H. curtus proteins, as calculated by exPASy. Average exPASy calculated molecular weights (exPASy MW) are in brackets after related proteins
where a similar molecular weight was detected by ESI-MS in the same peak. Unused score values and the number of peptides and coverage (Cov) with ≥95% confidence are calculated
with the Paragon algorithm of ProteinPilot. Protein family abbreviations: 3FTx = three-finger toxin; CRISP = cysteine-rich secretory protein; PLA2 = phospholipase A2; SVMP = snake
venom metalloproteinase; PEBP = phosphatidylethanolamine-binding protein; Hsp70 = heat shock protein; Cys = cystatin; Golgin = golgin; Trans = transferrin; Nucleo = nucleobindin;
CTL = C-type lectin; PC1A = Peptidase C1A. Cysteine residues are carbamidomethylated. Full details of MS/MS-derived sequences and the masses and charges of peptide ions for
ProteinPilot searches can be found in the Supplementary Material (Supplementary Tables S1–S4).
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2.3. Relative Protein Abundance Estimations Using MASCOT emPAI
Figure 5 shows the relative abundances of toxin families in pooled January (adult) and June
(subadult) H. curtus venoms, which were calculated with MASCOT exponentially-modified protein
abundance index (emPAI) scores from searches against the UniProtKB Serpentes database. In both
January and June venoms, PLA2 is most abundant. In January venom, the total PLA2 is 66.7% (57.93%
acidic PLA2 and 8.76% basic PLA2), while in June venom, the total PLA2 makes up a smaller proportion
of the venom at 54.5% (41.21% acidic PLA2 and 13.28% basic PLA2). The acidic portion is composed
almost entirely of one toxin, acidic phospholipase A2 57 (Q8UW31), making it the most abundant toxin
in the venom. 3FTx makes up most of the remainder in both venoms. January venom contains a total of
30.4% 3FTx (22.11% long-chain neurotoxins and 8.33% short-chain neurotoxins), while the proportion
of 3FTx in June venom is higher at 40.4%, which is largely due to a greater proportion of short-chain
neurotoxins (20.76%). The proportion of long-chain neurotoxins is similar between samples (19.67%
and 22.11% in June and January venoms, respectively). CRISP takes up 2.53% and 4.95% in January
and June venom respectively. Other components, including SVMP, C-type lectins and a handful of
house-keeping and regulatory proteins, are present in trace amounts.
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Figure 5. Composition of Hydrophis curtus venom by protein family for (A) January (adult) and (B) June
(subadult) pooled venoms, as calculated by MASCOT exponentially-modified protein abundance
index (emPAI) score. The pie charts show the relative abundances of phospholipase A2 (PLA2)
(acidic, basic and neutral), three-finger toxins (3FTx) (long-chain and short-chain), cysteine-rich
secretory protein (CRISP), snake venom metalloproteinase (SVMP), C-type lectins, cystatin, transferrin,
phosphatidylethanolamine-binding protein (PEBP), heat shock protein (Hsp70), extra-cellular matrix
protein (ECM1), PLA2 inhibitor, golgin and ribonuclease T2 (RNase T2).
3. iscussion
3.1. Assessment of Variation in H. curtus Venom
The present study provides the first proteomic characterisation of the H. curtus venom, including
venoms from two distinct seasons, January and June, which correspond to adults and subadults,
respectively. This allowed us to assess not only the individual variation in venom, but also if seasonal
and/or ontogenetic variation were present. Individual variation in toxin expression occurs regularly
in snakes [30], as does ontogenetic variation, which is often driven by a change in diet as the snake
matures to adulthood [31–34]; however, little evidence exists for seasonal variation [30]. In this sense,
variations of all kinds are a highly relevant consideration when producing antivenoms in order to
ensure all potential toxin activities can be neutralised [35,36].
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The minimal variation observed in the H. curtus venom tested was expected since all the samples
tested were collected within metres of each other from a sympatric population and there is no known
driver for venom variation in viviparous sea snakes such as ontogenetic or seasonal diet changes [4].
Comparisons of RP-HPLC chromatograms for individuals and pooled samples showed that the venom
was in fact remarkably similar. Despite that, one distinct difference emerged: the peak containing a
14,157-Da protein, which was found in some adult January animals. Since it was entirely absent from
the subadult animals, which were all milked in June, it is possible that seasonal or ontogenetic variation
is responsible for the difference. If June adults contain the protein and June subadults do not, it would
be evidence for ontogenetic rather than seasonal variation. However, as the single adult June venom
sample did not contain the protein, the question remains open. Because the protein only appears in
some adults, a third possibility is that H. curtus has sexual venom variation between adult males and
females. There is only a small amount of evidence of sexual venom variation in snakes [30,37,38], and
whether that is the case here remains to be investigated. A fourth possibility is that this is merely a case
of the individual variability typically found in snake venoms [30]. Whether or not the difference is
practically important will depend on how the 14,157-Da protein affects venom activity. The size of the
14,157-Da protein is consistent with PLA2, and nothing other than 3FTx, CRISP or PLA2 was identified
in that peak (Table 1). If the protein behaves similarly to other H. curtus PLA2 toxins, the practical
effect of the difference may be minimal, in both an ecological and clinical setting. Further research into
the reason for the difference and the activity of the protein is required. The variations that were found
in MALDI-TOF mass spectrometry, ESI-MS and RP-HPLC results underscore the need to use a large
and diverse pool of individuals for antivenom production [36], even in species that typically show
little variation such as sea snakes, especially when the effects of the variable proteins on humans are
not understood.
3.2. Protein Identification and Relative Abundance Estimations with ProteinPilot and MASCOT
Protein identifications were consistent with previously sequenced H. curtus toxins. Of the 14 toxins
previously identified, ProteinPilot consistently matched 10 (as the synonymous Hydrophis hardwickii)
(Table 1). A further two, both short-chain neurotoxins (Q8UW26 and Q8UW27), were regularly listed
as matches of lower significance or less commonly as equal winner proteins, across all ProteinPilot
searches (Supplementary Tables S1–S4). This is likely because both proteins are almost identical to
the short-chain neurotoxin that was identified (P68416), with only one amino acid different, and
ProteinPilot lacked the identifying peptide required to distinguish between them. A PLA2 (A3FM57)
was listed as a match of lower significance once, in Peak 5 of the ProteinPilot search against the
UniProtKB database of June venom (Supplementary Table S2). Only the serine protease harobin
(Q5MCS0) was not identified at all. Proteins from a number of other snake species were matched,
predominantly Australian terrestrial elapids (Table 1, Supplementary Tables S1–S8).
ESI-MS detected molecular weights similar to nine of the 14 known H. curtus toxins, as calculated
with the ExPASy pI/Mw calculator from known sequence data (Table 1). Those included all three
short-chain neurotoxins, providing further support for their presence. ESI-MS did not detect the
long-chain neurotoxins (A3FM53 and Q8UW29) and the C-type lectin (A3FM55) that were identified
by ProteinPilot. It also did not detect the PLA2 (A3FM57) or the serine protease harobin (Q5MCS0); nor
did ESI-MS detect molecular weights consistent with SVMP or most house-keeping proteins. Possible
reasons for the failed detections in protein identification software and ESI-MS could be because the
proteins are present only in trace quantities or are absent or different in Australian H. curtus venom
compared with the Asian H. curtus specimens usually studied. Additionally, if the protein were
identified from venom gland mRNA, as was the case for serine protease harobin (Q5MCS0) [24], it may
not be readily expressed in the proteome.
The MASCOT emPAI protocol was employed to calculate the relative abundances of protein
families in H. curtus venom. The emPAI score is proportional to the amount of an individual protein
present in a mixed sample and has been found to produce equivalent results to protein staining
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methods [39]. The proteomic characterisation of H. curtus venom by LC-ESI-MS/MS, ProteinPilot
and MASCOT confirmed that the protein families 3FTx and PLA2 dominate the venom (Table 1,
Supplementary Tables S1–S8), continuing the trend found in all other sea snake venoms studied
so far [6–9]. In H. curtus, PLA2 was the most abundant protein family, contrasting with Hydrophis
cyanocinctus, Hydrophis schistosus and Hydrophis platurus, in which 3FTx is dominant [7–9]. PLA2
dominance of the venom is a distinction H. curtus shares with only one other sea snake that has
been proteomically characterised, the olive sea snake (Aipysurus laevis) [6]. Until the A. laevis venom
was characterised, 3FTx appeared to be dominant in the majority of sea snake venoms [7–9], even
in H. curtus, where a previous investigation indicated that the venom included 43.4% 3FTx and 9.8%
PLA2 [28]. However, this study was based on cDNA libraries cloned from venom gland mRNA, and
the results might reflect a bias towards 3FTx mRNA in the cDNA method used or indicate that proteins
are not translated from mRNA in a directly proportional manner [40].
The apparent dominance of 3FTx in the majority of sea snakes suggests that sea snake venoms
should be neurotoxic to humans, as elapid short- and long-chain α-neurotoxins cause respiratory
paralysis by binding to skeletal muscle nicotinic acetylcholine receptors (nAChRs) and, in the case of
long-chain α-neurotoxins, neuronal α7 nAChR [41]. However, sea snake envenomations in humans are
predominantly myotoxic, less often neurotoxic and rarely both [11,42]. It has been suggested that some
short-chain sea snake neurotoxins are not as effective on humans due to an amino acid difference in the
neuromuscular nAChR [43]. The results of the present study suggest an additional reason for human
clinical presentation is interspecific, and possibly intraspecific, variations in the proportions of the
two dominant components and, at a finer scale, the proportions of acidic and basic PLA2 components.
PLA2 causes the breakdown of skeletal myofilaments [44,45] by inducing cellular degeneration with
an influx of Ca2+ ions [46]. Some basic PLA2 toxins are more effective at penetrating the phospholipid
bilayer than acidic PLA2 toxins [47,48], suggesting that a venom with a higher proportion of basic
PLA2 would be a more effective myotoxin. The presence and proportion of basic and acidic PLA2
unquestionably differs between sea snakes: H. curtus, H. schistosus and H. platurus have both types [8,9],
whereas all A. laevis PLA2s appear to be acidic [6]. Therefore, in sea snake envenomations, the effective
proportion of either dominant protein family may be entirely different from the actual proportion.
It would be useful to conduct an epidemiological study of worldwide sea snake envenomations to see
if there is a correlation between the clinical effects of envenomation and the dominant toxin families or
their subtypes in the species responsible.
Ecologically, it is unclear why the most dominant protein family alternates between 3FTx and
PLA2 in different sea snake species. Nearly all sea snakes are teleost feeders [4], a comparatively
limited diet that could result in sea snakes employing similar proportions of toxin families, yet this
is not the case. It would be interesting to see if there is a connection between the proportions of
toxin families and subtypes that make up the venom and dietary parameters such as size and type,
as well as the degree of variation in prey eaten. Notably, there is a greater proportion of short-chain
3FTx and a corresponding decrease in the proportion of acidic PLA2 in the June subadult venom pool
compared with the January adult venom pool (Figure 5). As with the 14,157-Da protein, this may
indicate seasonal, sexual or ontogenetic variation, but it is hard to know if there is any ecological
or clinical significance to this difference without further investigation. It would be worth analysing
the venom of neonate H. curtus snakes to see if there is an even more distinct difference with the
adult venom pool and/or investigating the lifetime diet of H. curtus to detect any change that might
indicate seasonal or ontogenetic changes in venom. It has been suggested that PLA2 in sea snakes
has a digestive role [8]. If so, it is possible that adult snakes could require more PLA2 to digest larger
prey, whereas for small snakes, the ability to quickly immobilise prey with neurotoxins might be more
important. A lower abundance of PLA2 in the venom of juveniles of some other elapid species when
compared with the adult venoms has been previously observed, such as the Australian Pseudonaja
textilis and Pseudonaja affinis [49] and the Asian Naja atra and Naja kaouthia [50,51]. Together with the
findings in the present study, this may indicate a trend across the elapid group.
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3.3. Toxin Diversity in H. curtus Venom
Although H. curtus venom was simple by the number of toxins families, it was unexpectedly diverse
by the number of unique molecules. The ESI-MS data in Table 1 list a large number of unique molecular
weights that did not match any known H. curtus toxin. This contrasts with a study that identified
13 molecular weights in Australian H. curtus venom using LC-ESI-MS [5], compared with 49 for pooled
January venom and 44 for pooled June venom in the present study. The discrepancy is likely because the
original study was conducted 14 years ago in 2003 when LC-ESI-MS was much less sensitive. Molecular
weights consistent with 3FTx, PLA2 and CRISP toxin families were found in both studies, so the number
of toxin families in H. curtus venom likely remains the same. However, the strong likelihood is that
there are a number of novel isoforms within those families, particularly in PLA2, which makes up
59% of the number of unique molecules for both January and June pools. Furthermore, ProteinPilot
identified <35% (at 95% confidence) of total MS/MS spectra in each RP-HPLC peak, and MASCOT
was also unable to assign a large number of peptides to a match. This implies that there are proteins
in the venom that have no homologs in either the NCBI or UniProtKB Serpentes databases, despite
the comprehensive nature of both. Finally, in the protein identification results, there were matches to
several toxins from venomous terrestrial elapids, suggesting that some sequences in H. curtus toxins
are different from known toxins of any sea snake species. In this regard, a reference genome or a
transcriptomic study will help in the identification of novel molecules present in the venom.
The possibility that H. curtus venom is more biochemically complex than currently understood
has implications for sea snake antivenom manufacture and development and calls into question
the idea that sea snakes possess minimal isoform diversity. Previous studies have shown limited
diversity in both the number of families and diversity of isoforms, especially when compared with
land snakes [5–7,9]. In H. curtus, however, toxin diversity is comparable to some terrestrial elapids
such as the African Naja spp., where 3FTx and PLA2 also dominate and toxin numbers range from
22–32 per species [52], and the Australian-Papuan Oxyuranus spp. [53]. The limited diet of sea snakes
is hypothesised to require only a minimal suite of toxins [5]. It is possible that H. curtus is an exception
to the rule as it is a generalist fish feeder [4] and therefore requires a greater range of toxins to subdue
prey. Certainly, the 2003 study [5] found that Australian H. curtus venom had the highest number
of toxins of any sea snake tested except for Malaysian H. curtus venom, which had 14. However, in
that same study, H. schistosus, which is a cat fish specialist [4], had an equivalent number of toxins
to Australian H. curtus venom. This may contradict the hypothesis that H. curtus, as a generalist
fish-feeder, possesses more toxin diversity, but further investigation is needed.
An updated LC-ESI-MS analysis of other sea snake venoms would give an indication of the
amount of toxin diversity present in individual species and across the entire group, but to completely
characterise the diversity of toxins in H. curtus and to verify that molecular weights detected by ESI-MS
are proteins with a unique amino acid sequence, sequences need to be confirmed. Determining the
extent of toxin diversity in sea snakes is important because if it is greater than currently believed,
efforts to develop a new sea snake antivenom based on human monoclonal antibodies or peptide-based
inhibitors as previously suggested [6] may be more complex than expected. However, the degree
of complexity will also depend on how different the toxins in sea snake venom are, by sequence or
activity, and what role they play in a human envenomation.
In conclusion, this study has provided insights into the proteomic composition of H. curtus venom.
It also indicated the presence of venom variation, which may be due to sexual, seasonal or ontogenetic
differences. We hope that further research will be undertaken to clarify the questions raised about the
ecological and clinical implications of our findings.
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4. Materials and Methods
4.1. Venom Samples
Hydrophis curtus venom was collected from wild individuals caught at Hey Point, Weipa
(12◦43203246.6” S 141◦53′34.4” E) in the Gulf of Carpentaria, Australia, on two separate field trips. The
first samples were collected from 11 adult specimens in January 2016. Samples from one adult and
10 subadults were collected in June 2016, where “subadult” is defined as an individual < 400 mm in
total length and “adult” is an individual > 600 mm in total length. The sexes of the snakes are unknown.
All venom samples were stored in liquid nitrogen during transport, then lyophilised and stored at
−80 ◦C. Approval to collect venom from wild sea snakes was granted by the James Cook University
Experimentation Ethics Review Committee under Approval Number A1575, September 2010.
4.2. Pooling Venom Samples
All samples of lyophilised H. curtus venom, except for the single June adult, were resuspended
separately in 500 µL of Milli-Q (MQ; Merck Millipore, Bayswater, Victoria, Australia) water and pooled
into their respective group, January or June. Thirty microliter of each sample were set aside to test for
intraspecific variation. Pooled venom was separated into 100-µL aliquots, lyophilised and stored at
−80 ◦C. Venom was pooled in order to investigate the average venom composition of the population
at the respective time point.
4.3. Venom Fractionation and Comparative Profiling with Reversed-Phase HPLC
RP-HPLC was performed on all individual samples and on the January and June pools, which
were resuspended in 30 µL of MQ water. Using an Agilent 1260 HPLC (Agilent, Santa Clara, CA,
USA), a total of 20 and 25 µL from the individual and pooled samples respectively was injected
into a C4 column (Phenomenex Jupiter, 4.6 mm × 250 mm, 5 µm particle diameter, pore size 300 Å)
(Phenomenex, Torrance, CA, USA), with a column oven temperature of 35 ◦C. The sample was eluted
using a linear gradient of 0.05% trifluoroacetic acid (TFA; Auspep, Tullamarine, Victoria, Australia)
in MQ water (Buffer A) and 90% acetonitrile (ACN; Sigma-Aldrich, St Louis, MO, USA) with 0.045%
TFA in MQ water (Buffer B) (0–60% B over 60 min; 60–90% B over 5 min; 90% B for 10 min; and 90–0%
B over 5 min) at 1 mL/min. Absorbance was monitored at 214-nm, and fractions for both pooled
samples were collected automatically into a 96-well, 1.09-mL deep well plate (Axygen, Union City,
CA, USA) in one-minute intervals. ChemStation C.01.03 software (Agilent, Santa Clara, CA, USA) was
used to standardise the base lines and calculate peak areas for each chromatogram.
4.4. Venom ‘Fingerprint’ Analysis Using LC-MS
Venom fingerprint analysis of January individuals was performed using RP-HPLC and a SCIEX
TOF/TOF™ 5800 MALDI mass spectrometer (SCIEX, Framingham, MA, USA), mixing 0.7 µL of sample
with 0.7 µL α-cyano-4-hydroxycinnamic acid (CHCA; Sigma-Aldrich, St. Louis, MO, USA) matrix at
7.5 mg/mL in 50% ACN/0.1% TFA onto an Opti-TOF 384-well plate. Venom fingerprint analysis of
the pooled venoms, the June subadult venoms and the single June adult venom was conducted using
a Shimadzu LC-MS 2020 single quadrupole mass spectrometer coupled with a Shimadzu Prominence
HPLC system (Shimadzu, Kyoto, Japan). Five microliter of each H. curtus sample were separated with
a Phenomenex XB-C18 column (Phenomenex Aeris, 2.1 mm × 150 mm, 3.6-µm particle diameter, pore
size 100 Å) (Phenomenex, Torrance, CA, USA) at a flow rate of 250 µL/min and using a linear gradient
of 0.1% formic acid (FA; Sigma-Aldrich, St. Louis, MO, USA) in MQ water (Buffer A) and 90% ACN
(Sigma-Aldrich, St. Louis, MO, USA) with 0.09% FA in MQ water (Buffer B) (0–60% B over 60 min;
60–90% B over 5 min; 90% B for 5 min; and 90–0% B over 5 min). ESI-MS data were collected in profile
acquisition mode (positive) over a scan range of 250–2000 m/z. Molecular weights were reconstructed
from ion series using the ‘multi-charged ion analysis’ module of the Shimadzu LabSolutions software
(Version 5.80) (Shimadzu, Kyoto, Japan).
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4.5. In-Solution Trypsin Digestion
Fractions in the pooled samples corresponding to RP-HPLC peaks were lyophilised and
reconstituted in 10 µL of 55 mM ammonium bicarbonate, vortexed for 10 s and centrifuged for 2 min at
16,000× g (5415D Eppendorf centrifuge). Where a peak comprised more than one fraction, these were
combined. Samples were reduced with 2 mM 1,4-dithiothreitol (DTT; Roche, Basel, Switzerland) for
20 min at 65 ◦C, then alkylated (5.5 mM iodoacetamide; Sigma-Aldrich, St. Louis, MO, USA) for 30 min
in darkness. An additional 10 mM DTT was added to samples, which were incubated for 30 min then
digested overnight in proteomics-grade trypsin (Sigma-Aldrich, St. Louis, MO, USA) at 37 ◦C and
quenched with 5% FA.
4.6. LC-ESI-MS/MS Tandem Mass Spectrometry
Tryptic digest samples were desalted with Millipore ZipTip® C18 resin pipette tips (Millipore,
Burlington, MA, USA) according to the manufacturer’s protocol, lyophilised and analysed in an Eksigent
NanoLC Ultra (Eksigent, Framingham MA, USA) coupled with a SCIEX TripleTOF 5600 fitted with a
NanoSpray III source (both SCIEX, Framingham, MA, USA). A total of 5 µL of each sample was injected
into a C18 trap column (Eksigent ChromXP C18CL, 10 mm × 0.3 mm, 5-µm particle diameter, pore size
120 Å) (Eksigent, Framingham, MA, USA), desalted at 3 µL/min for 15 min with 100% Buffer A (0.1%
FA) and separated in a C18 analytical column (Eksigent ChromXP C18CL, 0.075 mm × 150 mm, 3 µm
particle diameter, pore size 120 Å) (Eksigent, Framingham, MA, USA) using a flow rate of 250 nL/min
and a gradient of Buffer B (0.1% FA in ACN) as follows: 5–10% for 2 min; 10–40% over 58 min; 40–50%
for 5 min; 50–95% for 10 min; 95% for 15 min; 95–5% for 4 min; and 5% for 6 min. MS data were
acquired in positive TOF-MS mode using a scan range of 300–2000 Da with an accumulation time of
250 ms. Information-dependent acquisition was used to select precursor ions for MS/MS analysis with
a charge state of 2+–5+ exceeding 50 counts per second. MS/MS data were acquired in positive product
ion mode (high sensitivity), employing a scan range of 100–2000 Da. Both MS and MS/MS data were
acquired with an ion spray voltage of 2.4 kV, a curtain gas flow of 25 psi, a nebulising gas flow of 5 psi,
an interface heater temperature of 150 ◦C and a declustering potential of 80 V.
4.7. Protein Identification with ProteinPilot and MASCOT
MS/MS spectra from both pooled venoms were searched against the non-redundant NCBI
Serpentes database (taxid: 8570) [54] and the UniProtKB Serpentes database [55]. The searches were
conducted using ProteinPilot 4.0 with the Paragon algorithm (SCIEX, Framingham, MA, USA) and
the MASCOT server accessed via MASCOT Daemon 2.5.1 (Matrix-Science, London, UK). ProteinPilot
searches were conducted with a thorough search effort and a false discovery rate (FDR) analysis at
≥95% confidence, and matches were accepted only if the number of significant unique sequences ≥2.
MASCOT search parameters allowed up to two missed trypsin cleavages, a 50-ppm peptide tolerance
and a ±0.1-Da MS/MS tolerance. Carbamidomethylation of cysteine was set as a fixed modification
and oxidation of methionine and deamidation of asparagine and glutamine as variable modifications.
The FDR for peptide spectrum matches above homology was set to ≤1% and the number of significant
unique sequences to ≥2.
4.8. Relative Protein Abundance Estimations
The MASCOT exponentially-modified protein abundance index, or emPAI protocol
(Matrix-Science, London, UK), was employed to estimate the relative abundance of proteins in
H. curtus venom by protein family. For each peak identified by RP-HPLC, the emPAI score of each
matched protein was converted to a percentage of the total sum of the emPAI scores in the peak.
The percentage each protein contributed to the peak area was calculated accordingly using the peak
area from RP-HPLC chromatograms. Percentages were then added by protein family to compute the
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relative abundance of each family in the venom. Typical contaminants such as trypsin and keratin
were removed.
4.9. Calculating Molecular Weights from Existing H. curtus Sequences
The ExPASy “compute pI/Mw” tool (Swiss Institute of Bioinformatics, available online: web.
expasy.org/compute_pi) was used to calculate the theoretical average molecular weight of amino
acid sequences from proteomic and transcriptomic data found in the UniProtKB database [56]. The
molecular weight was calculated from the chain sequence, excluding signal peptides and propeptides.
Two mass units were subtracted from the calculated reduced peptide mass for every disulfide bond to
obtain the oxidised peptide mass.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/12/2695/s1.
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RNase T2 Ribonuclease T2
RP-HPLC Reversed-Phase High-Performance Liquid Chromatography
SVMP Snake Venom Metalloproteinase
SVSP Snake Venom Serine Protease
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Trans Transferrin
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